Sally Hunsberger

8.4k total citations · 1 hit paper
98 papers, 4.4k citations indexed

About

Sally Hunsberger is a scholar working on Statistics and Probability, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Sally Hunsberger has authored 98 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Statistics and Probability, 21 papers in Epidemiology and 18 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sally Hunsberger's work include Statistical Methods in Clinical Trials (20 papers), Statistical Methods and Bayesian Inference (15 papers) and Statistical Methods and Inference (13 papers). Sally Hunsberger is often cited by papers focused on Statistical Methods in Clinical Trials (20 papers), Statistical Methods and Bayesian Inference (15 papers) and Statistical Methods and Inference (13 papers). Sally Hunsberger collaborates with scholars based in United States, Mexico and United Kingdom. Sally Hunsberger's co-authors include Michael A. Proschan, Edward L. Korn, Larry Rubinstein, Jo Anne Zujewski, Robert J. Gray, Boris Freidlin, Kathleen I. Pritchard, Joseph A. Sparano, Clifford A. Hudis and William E. Barlow and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.

In The Last Decade

Sally Hunsberger

96 papers receiving 4.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System

2007 558 citations Sally Hunsberger et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sally Hunsberger United States	33	775	764	761	699	621	98	4.4k
Walter Lehmacher Germany	33	405 0.5×	626 0.8×	564 0.7×	420 0.6×	210 0.3×	143	4.9k
Thomas Braun United States	46	1.1k 1.4×	712 0.9×	504 0.7×	795 1.1×	296 0.5×	202	6.7k
Sylvan B. Green United States	34	1.1k 1.4×	657 0.9×	406 0.5×	1.0k 1.4×	550 0.9×	57	6.4k
Anne I. Goldman United States	36	1.2k 1.6×	264 0.3×	740 1.0×	676 1.0×	220 0.4×	73	5.1k
Mimi Kim United States	48	972 1.3×	156 0.2×	1.3k 1.7×	981 1.4×	487 0.8×	195	7.7k
James C. Boyd United States	38	576 0.7×	305 0.4×	171 0.2×	854 1.2×	427 0.7×	103	4.7k
Brent R. Logan United States	53	1.9k 2.5×	442 0.6×	1.5k 2.0×	643 0.9×	180 0.3×	244	8.4k
Motomi Mori United States	53	2.3k 3.0×	280 0.4×	701 0.9×	1.4k 2.0×	477 0.8×	157	9.0k
Peter Marks United States	29	783 1.0×	171 0.2×	343 0.5×	1.5k 2.2×	188 0.3×	103	5.0k
Eisuke Inoue Japan	39	509 0.7×	202 0.3×	275 0.4×	546 0.8×	207 0.3×	233	5.5k

Countries citing papers authored by Sally Hunsberger

Since Specialization

Citations

This map shows the geographic impact of Sally Hunsberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Hunsberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Hunsberger more than expected).

Fields of papers citing papers by Sally Hunsberger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Hunsberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Hunsberger. The network helps show where Sally Hunsberger may publish in the future.

Co-authorship network of co-authors of Sally Hunsberger

This figure shows the co-authorship network connecting the top 25 collaborators of Sally Hunsberger. A scholar is included among the top collaborators of Sally Hunsberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Hunsberger. Sally Hunsberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hunsberger, Sally, Susan S. Ellenberg, Steven Joffe, et al.. (2023). Monitoring Multiple U.S. Government–Supported Covid-19 Vaccine Trials. NEJM Evidence. 2(3). EVIDctcs2200301–EVIDctcs2200301.

Ortega‐Villa, Ana M., Ana A. Ortiz‐Hernández, Alejandra Ramírez‐Venegas, et al.. (2023). Etiology, clinical characteristics, and risk factors associated with severe influenza-like illnesses in Mexican adults. IJID Regions. 6. 152–158. 2 indexed citations

Friedman-Klabanoff, DeAnna, Megan Birkhold, Timothy R. Wilson, et al.. (2022). Safety and immunogenicity of AGS-v PLUS, a mosquito saliva peptide vaccine against arboviral diseases: A randomized, double-blind, placebo-controlled Phase 1 trial. EBioMedicine. 86. 104375–104375. 15 indexed citations

Belaunzarán-Zamudio, Pablo F., Allyson Mateja, Héctor Armando Rincón-León, et al.. (2021). Comparison of clinical characteristics of Zika and dengue symptomatic infections and other acute illnesses of unidentified origin in Mexico. PLoS neglected tropical diseases. 15(2). e0009133–e0009133. 7 indexed citations

Wang, Jing, Sally Hunsberger, John H. Powers, et al.. (2021). Quality of life of HIV-negative, previously healthy individuals following cryptococcal meningoencephalitis. Scientific Reports. 11(1). 3673–3673. 3 indexed citations

Han, Alison, Lindsay Czajkowski, Luz Angela Rosas, et al.. (2020). Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge Model. Clinical Infectious Diseases. 73(11). e4260–e4268. 36 indexed citations

Nishimura, Katherine K., Sally Hunsberger, John H. Beigel, et al.. (2016). Clinical characteristics of asthmatic patients with influenza-like illness and risk of severe exacerbations in Mexico. Annals of Allergy Asthma & Immunology. 116(5). 402–407. 2 indexed citations

Colombo, Rhonda E, Lori E. Dodd, Sally Hunsberger, et al.. (2015). A phase 1 randomized, double-blind, placebo-controlled, crossover trial of DAS181 (Fludase®) in adult subjects with well-controlled asthma. BMC Infectious Diseases. 16(1). 54–54. 17 indexed citations

McShane, Lisa M., Sally Hunsberger, & Alex A. Adjei. (2009). Effective Incorporation of Biomarkers into Phase II Trials. Clinical Cancer Research. 15(6). 1898–1905. 61 indexed citations

10.

Ballard‐Barbash, Rachel, Sally Hunsberger, Marianne Haenlein Alciati, et al.. (2009). Physical Activity, Weight Control, and Breast Cancer Risk and Survival: Clinical Trial Rationale and Design Considerations. JNCI Journal of the National Cancer Institute. 101(9). 630–643. 82 indexed citations

11.

Nathan, Paul C., Pamela L. Wolters, Seth M. Steinberg, et al.. (2006). Very high-dose methotrexate (33.6 g/m²) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P. Leukemia & lymphoma. 47(12). 2488–2504. 34 indexed citations

12.

Albert, Paul S. & Sally Hunsberger. (2005). On Analyzing Circadian Rhythms Data Using Nonlinear Mixed Models with Harmonic Terms. Biometrics. 61(4). 1115–1120. 32 indexed citations

13.

Hunsberger, Sally, Larry Rubinstein, Janet Dancey, & Edward L. Korn. (2005). Dose escalation trial designs based on a molecularly targeted endpoint. Statistics in Medicine. 24(14). 2171–2181. 56 indexed citations

14.

Vaz, Mário, et al.. (2002). Prediction equations for handgrip strength in healthy Indian male and female subjects encompassing a wide age range. Annals of Human Biology. 29(2). 131–141. 55 indexed citations

15.

Moss, Joel, et al.. (2001). Prevalence and Clinical Characteristics of Lymphangioleiomyomatosis (LAM) in Patients with Tuberous Sclerosis Complex. American Journal of Respiratory and Critical Care Medicine. 164(4). 669–671. 216 indexed citations

16.

Going, Scott B., Sarah Levin, J. Chuck Harrell, et al.. (1999). Physical activity assessment in American Indian schoolchildren in the Pathways study. American Journal of Clinical Nutrition. 69(4). 788S–795S. 54 indexed citations

17.

George, Elizabeth, Sally Hunsberger, D Savitha, & Prem Pais. (1999). Treatment of acute myocardial infarction: does the type of hospital make a difference? PPAMI Study Group.. PubMed. 51(2). 161–6. 15 indexed citations

18.

Hunsberger, Sally, et al.. (1998). Incidence, predictive factors and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure. Journal of the American College of Cardiology. 31. 218–218. 6 indexed citations

19.

French, Simone A., Mary Story, John H. Himes, et al.. (1997). Do Children Eat What They Say? Validity of Intended Food Choices Among Native American School Children. Obesity Research. 5(2). 87–92. 7 indexed citations

20.

Hunsberger, Sally, et al.. (1996). Design and analysis issues in pathways. The FASEB Journal. 10(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact